NSE: THYROCARE | BSE: 539871

Expensive Performer

Download real time

902.30 55.65 (6.57%)

High volume+gain today

NSE 25 Apr, 2025 3:31 PM (IST)

4,781.6

Market Cap

Above industry Median

0.4

Beta 1Year

Very Low volatility

Margin Growth

Thyrocare Technologies' EBITDA margin expands 8.9% YoY to 30.8% in Q4FY25 See details

Thyrocare Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for THYROCARE, BSE:539871 Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd.

22 Aug 2019

902.30

6.57%

Thyrocare Technologies Ltd: Revenues Enhanced by Volumes Growth

Buy: Thyrocare Technologies Ltd.

Karvy

Thyrocare Q1FY20 earnings came marginally higher than our estimates on account of healthy growth in samples collected

Thyrocare Technologi.. has an average target of 825.00 from 1 broker.

Thyrocare Technologies Ltd.

14 Aug 2019

902.30

6.57%

Q1FY20 Result Update

Buy: Thyrocare Technologies Ltd.

Target

Prabhudas Lilladhar

diagnostic tests. Overall, Thyrocar increased 10% price for its sick care business in B2B segment while price of few tests in preventive care marginally reduced in Q1FY20. Management guided that the benefits of price rationalization in Aarogyam 1.1, 1.2 and 1.3 will be visible in FY20E. Hence, we expect better traction in volumes and growth in the remaining three quarters of FY20E. Management guided for increased focus on B-2-B business with higher incentives and revenues per franchisee as it focusses...

Thyrocare Technologies Ltd. has gained 37.76% in the last 1 Year

Thyrocare Technologies Ltd.

06 Sep 2017

902.30

6.57%

Thyrocare Technologies Ltd

Mgmt Note: Thyrocare Technologies Ltd.

ICICI Securities Limited

We met the management of Thyrocare Technologies (Thyrocare) to get an insight into the company's future plans as well as industry dynamics. The company operates mainly in diagnostics and nuclear imaging segments, which contribute 89% and 6% to total revenues, respectively. The diagnostic segment operates on a hub-and-spoke model and currently comprises one automated central processing lab (CPL) in Navi Mumbai and eight regional processing labs (RPL). The samples are aggregated and sent to CPL and RPL from 26 air connected hubs and...